The oncology-based in-vivo CRO market is growing due to increasing demand for preclinical testing in cancer drug development. Rising R&D investment, growing oncology pipeline, and need for efficient drug evaluation are supporting market expansion through 2028. https://www.databridgemarketresearch.com/reports/global-oncology-based-in-vivo-contract-research-organization-cro-market